Sign in →

Test ID NARC Narcolepsy-Associated Antigen, HLA-DQB1 Typing, Blood

Useful For

Ruling out a diagnosis of narcolepsy

Method Name

Polymerase Chain Reaction (PCR)/Sequence-Specific Oligonucleotide Probes (SSO)

(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)

Reporting Name

Narcolepsy Associated Ag, B

Specimen Type

Whole Blood ACD-B

Specimen Required

Container/Tube: Yellow top (ACD solution B)

Specimen Volume: 6 mL

Collection Instructions: Do not transfer blood to other containers.

Additional Information: Specimen acceptability is based on extracted DNA concentration and not sample age.

Specimen Minimum Volume

3 mL

Specimen Stability Information

Specimen Type Temperature Time
Whole Blood ACD-B Refrigerated (preferred)
  Ambient 

Reference Values

An interpretive report will be provided.

Day(s) and Time(s) Performed

Monday through Friday; 7:30 a.m.-5:00 p.m.

Performing Laboratory

Mayo Medical Laboratories in Rochester

CPT Code Information

81376-HLA Class II typing, low resolution (eg, antigen equivalents); one locus (eg, HLA-DRB1/3/4/5, -DQB1, -DQA1, -DPB1, or -DPA1), each

LOINC Code Information

Test ID Test Order Name Order LOINC Value
NARC Narcolepsy Associated Ag, B In Process

 

Result ID Test Result Name Result LOINC Value
NARC_ Narcolepsy Associated Ag Result 53938-7
NARCC Interpretation No LOINC Needed

Test Classification

This test has been cleared or approved by the U.S. Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.